EDITORIAL SECTION

Articles

Medical Devices and Pharma: A Symbiotic Relationship for Improved Healthcare

The healthcare industry is continually evolving driven by technological advancements and innovative approaches to patient care Among the most significant developments is the symbiotic relationship between medical devices

From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma

Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes

How Pharma 4.0 Is Revolutionizing Drug Manufacturing

The pharmaceutical industry in the world is experiencing a digital transformation rejuvenated by the advent of Pharma an industry phenomenon that is based on Industry Due to the readjustment of the manufacturing industry to Industry the automation data interchange and intelligent ecosystem the pharmaceutical ecosystem is similarly being reorganized with Pharma technologies Research and develo...

Pharmaceutical Marketing in the Digital Age: Strategies and Challenges

Currently there is a great advancement in the use of technological solutions particularly under the modern pharma digital era Therefore with increase in knowledge dissemination through internet among the citizenry due to enhanced technology

How Cloud Computing and AI Revolutionize Pharmaceutical Supply Chain Management

The pharma supply chain management has been considered as one of the most complicated spheres of operations in any industry As opposed to the traditional supply chain pharmaceutical supply chains have to juggle patient safety regulatory compliance cold chain integrity global sourcing and unpredictable demand and cost pressures simultaneously

How AI Is Addressing Drug Development Challenges in Rare Diseases?

Healthcare struggles with persistent obstacles to treat and understand rare diseases which societies call orphan diseases While affecting a minority portion of individuals these rare diseases make therapy discovery difficult because of scarce research data and expensive evaluation costs alongside multifaceted disease pathways The rising use of artificial intelligence AI drives a transformative cha...

Techno Trends

Merck’s Calderasib Receives FDA Breakthrough Therapy Designation for Lung Cancer

Merck has secured a significant regulatory milestone for its investigational cancer therapy calderasib MK after the US Food and Drug Administration FDA granted the treatment Breakthrough Therapy designation

Projects

FUJIFILM Invests $200 Million to Expand iPSC Manufacturing Facility in Madison

FUJIFILM Cellular Dynamics Inc has opened a new headquarters and induced pluripotent stem cell iPSC development and manufacturing facility in Madison Wisconsin The project is part of Fujifilms previously announced

Research Insights

Knowledge gaps and positive attitudes toward adult vaccination among nursing students: A Cross-sectional study

Vaccination is one of the most effective publichealth measures yet adult coverage in Spain remains suboptimal due to misinformation and hesitancy

whitepaper

Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch

Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities